Filing Flows › Agape ATP (ATPC) › Q3 2025
Agape ATP (ATPC) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 13, 2025
Agape ATP (ATPC) reported revenue of $371K for the third quarter 2025 (Q3 2025), +12% from a year earlier and -20% from the quarter before. Operating margin was -162.3%, net loss $595K (160.7% of revenue).
Agape ATP, Q3 2025: revenue $371K (+12% year over year), operating margin -162.3%, net loss $595K, operating cash flow −$257K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $371K | -20% | +12% |
| Operating profit | −$601K | — | — |
| Net earnings | −$595K | — | — |
| Operating cash flow | −$257K | — | — |
What changed
Revenue was $371K in Q3 2025, up 12% year over year and down 20% from the previous quarter. Product Health Therapies was the largest line at 60% of revenue. Skin Care and Health Care Products added $72K year over year (up 392%), 184% of the total change. LIVO 5 declined 99%.
Gross margin was 64.5%, up 8.9 points from a year earlier. Operating costs exceeded revenue by $601K, an operating margin of -162.3%. Operating expenses grew 15% against revenue growth of 12%. The fastest-growing cost line was Other operating costs (+297%). The quarter ended with a net loss of $595K, narrower than the previous quarter's $617K loss. Minority interests bore $9K of it: to shareholders the quarter was a loss of $587K.
Operating cash flow was −$257K. Non-cash charges added back $3K of depreciation and amortization. Working capital and other items added $335K. Capital expenditures of $0K exceeded it, leaving free cash flow of −$257K.
Questions
What was Agape ATP's revenue in the third quarter 2025?
Agape ATP (ATPC) reported revenue of $371K for the third quarter 2025 (Q3 2025), +12% from a year earlier and -20% from the quarter before.
Was Agape ATP profitable in the third quarter 2025?
Operating loss was $601K (-162.3% of revenue) and net loss $595K.
Source: Agape ATP 10-Q on SEC EDGAR.